Compare LULU & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LULU | CRL |
|---|---|---|
| Founded | 1998 | 1947 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 13.1B |
| IPO Year | 2007 | 1999 |
| Metric | LULU | CRL |
|---|---|---|
| Price | $106.67 | $359.47 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 36 | 17 |
| Target Price | $103.66 | ★ $318.87 |
| AVG Volume (30 Days) | ★ 3.7M | 1.1M |
| Earning Date | 12-10-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 4.59 | N/A |
| Revenue | ★ $11,102,600,000.00 | $1,857,601,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.53 |
| P/E Ratio | $23.94 | ★ N/A |
| Revenue Growth | 4.86 | ★ 10.48 |
| 52 Week Low | $90.38 | $146.20 |
| 52 Week High | $225.98 | $379.63 |
| Indicator | LULU | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 58.34 | 67.03 |
| Support Level | $104.44 | $151.03 |
| Resistance Level | $123.24 | N/A |
| Average True Range (ATR) | 4.17 | 14.73 |
| MACD | 1.68 | 4.84 |
| Stochastic Oscillator | 74.57 | 74.15 |
Lululemon Athletica designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. The company offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. Lululemon also sells fitness accessories, such as bags, yoga mats, and equipment. It sells its products through digital channels, a small number of wholesale partners, more than 800 company-owned stores in about two dozen countries in North America, Asia, and Western Europe, and about 45 franchised locations in the Middle East and Europe. The company was founded in 1998 and is based in Vancouver, Canada.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.